Merz Revenue and Competitors
Estimated Revenue & Valuation
- Merz's estimated annual revenue is currently $181.1M per year.
- Merz's estimated revenue per employee is $201,000
Employee Data
- Merz has 901 Employees.
Merz's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO, Merz Americas | Reveal Email/Phone |
3 | CEO Merz Asia-Pacific | Reveal Email/Phone |
4 | CEO Merz Consumer Care | Reveal Email/Phone |
5 | General Counsel, North America at Merz Therapeutics | Reveal Email/Phone |
6 | Head Global Regulatory Operations | Reveal Email/Phone |
7 | VP Corporate Strategic Sourcing and Corporate IT | Reveal Email/Phone |
8 | Head Chemical Analytics, Leiterin der Qualitätskontrolle gem. AMWHV | Reveal Email/Phone |
9 | SVP | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
Merz Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is Merz?
Merz Pharma is an innovative and international healthcare company with its own research and development department. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.
keywords:N/AN/A
Total Funding
901
Number of Employees
$181.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Merz News
But other trends spawned by the pandemic fed the market for Merz Aesthetics' cosmetic-enhancement products: the Zoom boom, a greater...
Facial Rejuvenation Market is estimated to account for US$ 35,518.9 Mn | Merz Pharma, Anika Therapeutics, Inc., Lumenis, Galderma, Allergan (...
Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live...
Cytrellis Biosystems, a Boston, MA-based company developing a new class of non-surgical products to combat sagging skin associated with aging, received a strategic venture investment from Merz Pharma. The amount of the deal was not disclosed. Led by Doug Levinson, CEO and co-founder, Cytrellis ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $349.3M | 924 | 11% | N/A |
#2 | $129.5M | 925 | 6% | N/A |
#3 | $237.9M | 944 | 7% | N/A |
#4 | $231.4M | 950 | 6% | N/A |
#5 | $207.3M | 987 | -2% | N/A |